Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €51.10 by JPMorgan Chase & Co.


Share on StockTwits

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €51.10 ($60.12) target price from research analysts at JPMorgan Chase & Co. in a note issued to investors on Tuesday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential downside of 12.44% from the company’s current price.

Other analysts also recently issued research reports about the stock. Warburg Research set a €84.00 ($98.82) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Thursday, October 29th. Kepler Capital Markets set a €89.00 ($104.71) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Thursday, October 29th. Nord/LB set a €56.00 ($65.88) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Thursday, February 4th. Independent Research set a €76.00 ($89.41) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Wednesday, February 3rd. Finally, UBS Group set a €72.00 ($84.71) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, February 17th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of €70.18 ($82.56).

ETR FME opened at €58.36 ($68.66) on Tuesday. The stock has a market capitalization of $17.09 billion and a P/E ratio of 12.99. The business has a 50 day simple moving average of €64.87 and a 200 day simple moving average of €69.21. The company has a debt-to-equity ratio of 103.14, a current ratio of 1.11 and a quick ratio of 0.71. Fresenius Medical Care AG & Co. KGaA has a one year low of €53.50 ($62.94) and a one year high of €79.96 ($94.07).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: Support Level

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.